AC21 - Lola Fashoyin-Aje: Balancing Efficiency & Inclusivity to Develop Therapeutics that Work...

preview_player
Показать описание
Balancing Efficiency and Inclusivity to Develop Therapeutics that Work for All

from the 2021 Cholangiocarcinoma Annual Conference.
  1. Cholangiocarcinoma Foundation
Рекомендации по теме
AC21 - Lola 0:15:40

AC21 - Lola Fashoyin-Aje: Balancing Efficiency & Inclusivity to Develop Therapeutics that Work.....

2020 Symposium: FDA 0:50:20

2020 Symposium: FDA Oncology Center of Excellence Initiatives to Advance Patient Engagement

Improving diversity in 0:02:39

Improving diversity in clinical trial enrollment

2018 NMQF Leadership 1:02:25

2018 NMQF Leadership Summit and Spring Health Braintrust: Policy & Advocacy Plenary

AC21 - Conference 0:08:33

AC21 - Conference Closing

AC21 - Ghassan 0:11:56

AC21 - Ghassan Abou-Alfa: FGFR

Pemigatinib， CAS：1513857-77-6, Why 0:00:16

Pemigatinib， CAS：1513857-77-6, Why Price so low

FGFR Inhibitors in 0:09:55

FGFR Inhibitors in Development for CCA

Возможна ли замена 0:13:37

Возможна ли замена препаратов (антиPD-1, BRAF/MEK ингибиторы)? (Харкевич Г.Ю.)...

AC20 - Global 0:16:40

AC20 - Global Research Update

FIGHT-202 data: pemigatinib 0:02:14

FIGHT-202 data: pemigatinib for previously treated locally advanced/metastatic cholangiocarcinoma